Published in Mol Pharm on October 03, 2012
Nonfouling NTA-PEG-Based TEM Grid Coatings for Selective Capture of Histidine-Tagged Protein Targets from Cell Lysates. Langmuir (2016) 0.83
Acid-triggered release via dePEGylation of fusogenic liposomes mediated by heterobifunctional phenyl-substituted vinyl ethers with tunable pH-sensitivity. Bioconjug Chem (2012) 0.79
Stimuli-responsive liposomes for drug delivery. Wiley Interdiscip Rev Nanomed Nanobiotechnol (2017) 0.77
pH-responsive biodegradable assemblies containing tunable phenyl-substituted vinyl ethers for use as efficient gene delivery vehicles. ACS Appl Mater Interfaces (2013) 0.75
A rapid method of total lipid extraction and purification. Can J Biochem Physiol (1959) 173.74
Development of the Colle-Salvetti correlation-energy formula into a functional of the electron density. Phys Rev B Condens Matter (1988) 93.32
A new concept for macromolecular therapeutics in cancer chemotherapy: mechanism of tumoritropic accumulation of proteins and the antitumor agent smancs. Cancer Res (1986) 15.83
Diffusion of univalent ions across the lamellae of swollen phospholipids. J Mol Biol (1965) 7.58
Production of large unilamellar vesicles by a rapid extrusion procedure: characterization of size distribution, trapped volume and ability to maintain a membrane potential. Biochim Biophys Acta (1985) 4.47
Anti-HER2 immunoliposomes: enhanced efficacy attributable to targeted delivery. Clin Cancer Res (2002) 3.14
Transmembrane ammonium sulfate gradients in liposomes produce efficient and stable entrapment of amphipathic weak bases. Biochim Biophys Acta (1993) 2.92
Delivery of molecular and cellular medicine to solid tumors. Adv Drug Deliv Rev (2001) 2.83
Tumor-selective delivery of macromolecular drugs via the EPR effect: background and future prospects. Bioconjug Chem (2010) 2.72
Nanomedicine(s) under the microscope. Mol Pharm (2011) 2.09
Acidification of endosome subpopulations in wild-type Chinese hamster ovary cells and temperature-sensitive acidification-defective mutants. J Cell Biol (1989) 1.97
Targeting to cells of fluorescent liposomes covalently coupled with monoclonal antibody or protein A. Nature (1980) 1.82
Endocytosis and intracellular fate of liposomes using pyranine as a probe. Biochemistry (1990) 1.60
Tumor detection using folate receptor-targeted imaging agents. Cancer Metastasis Rev (2008) 1.58
Cytosolic drug delivery using pH- and light-sensitive liposomes. Adv Drug Deliv Rev (1999) 1.52
Uptake of adriamycin into large unilamellar vesicles in response to a pH gradient. Biochim Biophys Acta (1986) 1.52
Antibody targeting of liposomes: cell specificity obtained by conjugation of F(ab')2 to vesicle surface. Science (1980) 1.48
Design, synthesis, and characterization of pH-sensitive PEG-PE conjugates for stimuli-sensitive pharmaceutical nanocarriers: the effect of substitutes at the hydrazone linkage on the ph stability of PEG-PE conjugates. Bioconjug Chem (2007) 1.43
Acetals as pH-sensitive linkages for drug delivery. Bioconjug Chem (2004) 1.37
Liposomal drug formulations. Rationale for development and what we can expect for the future. Drugs (1998) 1.29
Steric stabilization of fusogenic liposomes by a low-pH sensitive PEG--diortho ester--lipid conjugate. Bioconjug Chem (2001) 1.28
Folate-mediated intracellular drug delivery increases the anticancer efficacy of nanoparticulate formulation of arsenic trioxide. Mol Cancer Ther (2009) 1.27
Lipid encapsulation of arsenic trioxide attenuates cytotoxicity and allows for controlled anticancer drug release. J Am Chem Soc (2006) 1.27
Loading mitomycin C inside long circulating hyaluronan targeted nano-liposomes increases its antitumor activity in three mice tumor models. Int J Cancer (2004) 1.26
Measurement of endosome pH following folate receptor-mediated endocytosis. Biochim Biophys Acta (1996) 1.25
Fusion of phosphatidylethanolamine-containing liposomes and mechanism of the L alpha-HII phase transition. Biochemistry (1986) 1.24
Rate of biodistribution of STEALTH liposomes to tumor and skin: influence of liposome diameter and implications for toxicity and therapeutic activity. Biochim Biophys Acta (2003) 1.21
Low-pH-sensitive poly(ethylene glycol) (PEG)-stabilized plasmid nanolipoparticles: effects of PEG chain length, lipid composition and assembly conditions on gene delivery. J Gene Med (2005) 1.19
Gelation of liposome interior. A novel method for drug encapsulation. FEBS Lett (1992) 1.19
Uptake of antineoplastic agents into large unilamellar vesicles in response to a membrane potential. Biochim Biophys Acta (1985) 1.18
Acid-triggered release via dePEGylation of DOPE liposomes containing acid-labile vinyl ether PEG-lipids. J Control Release (2003) 1.16
Endocytosis of liposomes by macrophages: binding, acidification and leakage of liposomes monitored by a new fluorescence assay. Biochim Biophys Acta (1990) 1.14
64Cu loaded liposomes as positron emission tomography imaging agents. Biomaterials (2011) 1.13
New detachable poly(ethylene glycol) conjugates: cysteine-cleavable lipopolymers regenerating natural phospholipid, diacyl phosphatidylethanolamine. Bioconjug Chem (1999) 1.13
Poly(ethylene glycol)-lipid conjugates promote bilayer formation in mixtures of non-bilayer-forming lipids. Biochemistry (1996) 1.11
Controlled destabilization of a liposomal drug delivery system enhances mitoxantrone antitumor activity. Nat Biotechnol (1999) 1.10
Targeted delivery and triggered release of liposomal doxorubicin enhances cytotoxicity against human B lymphoma cells. Biochim Biophys Acta (2001) 1.09
Interbilayer transfer of phospholipid-anchored macromolecules via monomer diffusion. Biochemistry (1993) 1.09
Liposomes with detachable polymer coating: destabilization and fusion of dioleoylphosphatidylethanolamine vesicles triggered by cleavage of surface-grafted poly(ethylene glycol). FEBS Lett (1996) 1.08
Evaluating nanoparticle sensor design for intracellular pH measurements. ACS Nano (2011) 1.07
An imaging-driven model for liposomal stability and circulation. Mol Pharm (2010) 1.05
Degradable conjugates from oxanorbornadiene reagents. J Am Chem Soc (2012) 1.03
Pharmaco attributes of dioleoylphosphatidylethanolamine/cholesterylhemisuccinate liposomes containing different types of cleavable lipopolymers. Pharmacol Res (2004) 0.97
Antitumor activity of an epithelial cell adhesion molecule targeted nanovesicular drug delivery system. Mol Cancer Ther (2007) 0.97
Mechanism of pH-triggered collapse of phosphatidylethanolamine liposomes stabilized by an ortho ester polyethyleneglycol lipid. Biophys J (2003) 0.96
Membrane contact, fusion, and hexagonal (HII) transitions in phosphatidylethanolamine liposomes. Biochemistry (1990) 0.96
Enzyme-triggered nanomedicine: drug release strategies in cancer therapy. Mol Membr Biol (2010) 0.96
Development of a highly stable and targetable nanoliposomal formulation of topotecan. J Control Release (2009) 0.92
HIV TAT peptide modifies the distribution of DNA nanolipoparticles following convection-enhanced delivery. Mol Ther (2008) 0.91
Interactions between pH-sensitive liposomes and model membranes. Biophys Chem (2003) 0.91
Cytoplasmic delivery of liposomal contents mediated by an acid-labile cholesterol-vinyl ether-PEG conjugate. Bioconjug Chem (2009) 0.90
125I labelled inulin: a convenient marker for deposition of liposomal contents in vivo. Biochem Biophys Res Commun (1984) 0.89
Acidic hydrolysis of N-Ethoxybenzylimidazoles (NEBIs): potential applications as pH-sensitive linkers for drug delivery. Bioconjug Chem (2007) 0.88
Association of hydrophobically-modified poly(ethylene glycol) with fusogenic liposomes. Biochim Biophys Acta (2003) 0.87
Intermembrane transfer of polyethylene glycol-modified phosphatidylethanolamine as a means to reveal surface-associated binding ligands on liposomes. Biochim Biophys Acta (2001) 0.87
Development of the novel PEG-PE-based polymer for the reversible attachment of specific ligands to liposomes: synthesis and in vitro characterization. Bioconjug Chem (2011) 0.85
Pharmacokinetics of differently designed immunoliposome formulations in rats with or without hepatic colon cancer metastases. Pharm Res (2001) 0.84
Chloroaluminum phthalocyanine tetrasulfonate delivered via acid-labile diplasmenylcholine-folate liposomes: intracellular localization and synergistic phototoxicity. Int J Cancer (2001) 0.83
Polymeric nanosensors for measuring the full dynamic pH range of endosomes and lysosomes in mammalian cells. J Biomed Nanotechnol (2009) 0.81
Programmable fusogenic vesicles for intracellular delivery of antisense oligodeoxynucleotides: enhanced cellular uptake and biological effects. Biochim Biophys Acta (2001) 0.80
Sonolysis promotes indirect Co-C bond cleavage of alkylcob(III)alamin bioconjugates. Bioconjug Chem (1997) 0.78
The ratio of phosphatidylcholine to phosphatidylethanolamine influences membrane integrity and steatohepatitis. Cell Metab (2006) 2.03
Determination of doxorubicin levels in whole tumor and tumor nuclei in murine breast cancer tumors. Clin Cancer Res (2005) 1.81
Selective detection of protein crystals by second harmonic microscopy. J Am Chem Soc (2008) 1.64
Vascular damage and anti-angiogenic effects of tumor vessel-targeted liposomal chemotherapy. Cancer Res (2003) 1.45
Synthesis and grafting of thioctic acid-PEG-folate conjugates onto Au nanoparticles for selective targeting of folate receptor-positive tumor cells. Bioconjug Chem (2006) 1.42
Targeting liposomal chemotherapy via both tumor cell-specific and tumor vasculature-specific ligands potentiates therapeutic efficacy. Cancer Res (2006) 1.37
Ligand-targeted liposomes for cancer treatment. Curr Drug Deliv (2005) 1.32
Folate-mediated intracellular drug delivery increases the anticancer efficacy of nanoparticulate formulation of arsenic trioxide. Mol Cancer Ther (2009) 1.27
Optical imaging of metastatic tumors using a folate-targeted fluorescent probe. J Biomed Opt (2003) 1.26
Drug release rate influences the pharmacokinetics, biodistribution, therapeutic activity, and toxicity of pegylated liposomal doxorubicin formulations in murine breast cancer. Biochim Biophys Acta (2004) 1.22
Rate of biodistribution of STEALTH liposomes to tumor and skin: influence of liposome diameter and implications for toxicity and therapeutic activity. Biochim Biophys Acta (2003) 1.21
Internalizing antibodies are necessary for improved therapeutic efficacy of antibody-targeted liposomal drugs. Cancer Res (2002) 1.18
Acid-triggered release via dePEGylation of DOPE liposomes containing acid-labile vinyl ether PEG-lipids. J Control Release (2003) 1.16
Enhanced antitumor efficacy of clinical-grade vasculature-targeted liposomal doxorubicin. Clin Cancer Res (2008) 1.14
Targeted delivery of anti-CD19 liposomal doxorubicin in B-cell lymphoma: a comparison of whole monoclonal antibody, Fab' fragments and single chain Fv. J Control Release (2007) 1.14
Doxorubicin-loaded Fab' fragments of anti-disialoganglioside immunoliposomes selectively inhibit the growth and dissemination of human neuroblastoma in nude mice. Cancer Res (2003) 1.12
Use of the post-insertion method for the formation of ligand-coupled liposomes. Cell Mol Biol Lett (2002) 1.06
Multiple injections of pegylated liposomal Doxorubicin: pharmacokinetics and therapeutic activity. J Pharmacol Exp Ther (2003) 1.05
Ligand-receptor interactions between surfaces: the role of binary polymer spacers. Langmuir (2008) 1.04
Functional reconstitution of the integral membrane enzyme, isoprenylcysteine carboxyl methyltransferase, in synthetic bolalipid membrane vesicles. Biochemistry (2006) 1.04
Cytotoxic analogues of 2,6-bis(arylidene)cyclohexanones. Eur J Med Chem (2003) 1.04
Rapid detection of S-adenosyl homocysteine using self-assembled optical diffraction gratings. Angew Chem Int Ed Engl (2008) 1.02
Cytotoxic 1,3-diarylidene-2-tetralones and related compounds. Eur J Med Chem (2002) 0.99
A general fluorescence-based coupled assay for S-adenosylmethionine-dependent methyltransferases. Biochem Biophys Res Commun (2005) 0.99
Targeted liposomal c-myc antisense oligodeoxynucleotides induce apoptosis and inhibit tumor growth and metastases in human melanoma models. Clin Cancer Res (2003) 0.98
Pharmaco attributes of dioleoylphosphatidylethanolamine/cholesterylhemisuccinate liposomes containing different types of cleavable lipopolymers. Pharmacol Res (2004) 0.97
Antitumor activity of an epithelial cell adhesion molecule targeted nanovesicular drug delivery system. Mol Cancer Ther (2007) 0.97
Selective therapeutic targeting of the anaplastic lymphoma kinase with liposomal siRNA induces apoptosis and inhibits angiogenesis in neuroblastoma. Mol Ther (2011) 0.96
Enzyme-triggered nanomedicine: drug release strategies in cancer therapy. Mol Membr Biol (2010) 0.96
Combined targeting of perivascular and endothelial tumor cells enhances anti-tumor efficacy of liposomal chemotherapy in neuroblastoma. J Control Release (2010) 0.96
Use of the post-insertion technique to insert peptide ligands into pre-formed stealth liposomes with retention of binding activity and cytotoxicity. Pharm Res (2002) 0.94
Neuroblastoma-targeted nanoparticles entrapping siRNA specifically knockdown ALK. Mol Ther (2011) 0.94
Pendant polymer:amino-β-cyclodextrin:siRNA guest:host nanoparticles as efficient vectors for gene silencing. J Am Chem Soc (2012) 0.94
Specific adsorption of histidine-tagged proteins on silica surfaces modified with Ni2+/NTA-derivatized poly(ethylene glycol). Langmuir (2007) 0.93
Synthesis of 2-hydroxypropyl-β-cyclodextrin/pluronic-based polyrotaxanes via heterogeneous reaction as potential Niemann-Pick type C therapeutics. Biomacromolecules (2013) 0.93
Improved outcome when B-cell lymphoma is treated with combinations of immunoliposomal anticancer drugs targeted to both the CD19 and CD20 epitopes. Clin Cancer Res (2004) 0.93
Synthesis, characterization, and evaluation of pluronic-based β-cyclodextrin polyrotaxanes for mobilization of accumulated cholesterol from Niemann-Pick type C fibroblasts. Biochemistry (2013) 0.92
Immune cell-mediated antitumor activities of GD2-targeted liposomal c-myb antisense oligonucleotides containing CpG motifs. J Natl Cancer Inst (2004) 0.92
Improved therapeutic responses in a xenograft model of human B lymphoma (Namalwa) for liposomal vincristine versus liposomal doxorubicin targeted via anti-CD19 IgG2a or Fab' fragments. Clin Cancer Res (2004) 0.91
Interactions between pH-sensitive liposomes and model membranes. Biophys Chem (2003) 0.91
Cytoplasmic delivery of liposomal contents mediated by an acid-labile cholesterol-vinyl ether-PEG conjugate. Bioconjug Chem (2009) 0.90
Synthesis, characterization, and pH-triggered dethreading of alpha-cyclodextrin-poly(ethylene glycol) polyrotaxanes bearing cleavable endcaps. Biomacromolecules (2006) 0.90
Correlations between cytotoxicity and topography of some 2-arylidenebenzocycloalkanones determined by X-ray crystallography. J Med Chem (2002) 0.90
Size and structure of spontaneously forming liposomes in lipid/PEG-lipid mixtures. Biophys J (2002) 0.90
Cationic α-cyclodextrin:poly(ethylene glycol) polyrotaxanes for siRNA delivery. Mol Pharm (2013) 0.90
Phase separation in binary mixtures of bipolar and monopolar lipid dispersions revealed by 2H NMR spectroscopy, small angle x-ray scattering, and molecular theory. Biophys J (2009) 0.88
Stability and phase separation in mixed monopolar lipid/bolalipid layers. Biophys J (2007) 0.87
Bolalipid membrane structure revealed by solid-state 2H NMR spectroscopy. J Am Chem Soc (2008) 0.86
Challenges and opportunities for new protein crystallization strategies in structure-based drug design. Expert Opin Drug Discov (2010) 0.86
Increase of therapeutic effects by treating melanoma with targeted combinations of c-myc antisense and doxorubicin. J Control Release (2007) 0.86
Multi-armed cationic cyclodextrin:poly(ethylene glycol) polyrotaxanes as efficient gene silencing vectors. Integr Biol (Camb) (2013) 0.85
Treatment of colorectal cancer using a combination of liposomal irinotecan (Irinophore C™) and 5-fluorouracil. PLoS One (2013) 0.85
Cytotoxic N-[4-(3-aryl-3-oxo-1-propenyl)phenylcarbonyl]-3,5-bis(phenylmethylene)-4-piperidones and related compounds. Eur J Med Chem (2002) 0.84
Interaction of differently designed immunoliposomes with colon cancer cells and Kupffer cells. An in vitro comparison. Pharm Res (2003) 0.84
Novel phage display-derived neuroblastoma-targeting peptides potentiate the effect of drug nanocarriers in preclinical settings. J Control Release (2013) 0.84
Lipid-derivatized poly(ethylene glycol) micellar formulations of benzoporphyrin derivatives. J Control Release (2003) 0.83
Formation of plasmid-based transfection complexes with an acid-labile cationic lipid: characterization of in vitro and in vivo gene transfer. Pharm Res (2002) 0.83
Adventures in targeting. J Liposome Res (2003) 0.83
In vitro and in vivo antitumor activity of liposomal Fenretinide targeted to human neuroblastoma. Int J Cancer (2003) 0.83
High efficiency entrapment of antisense oligonucleotides in liposomes. Methods Enzymol (2004) 0.83
Liposome-mediated therapy of neuroblastoma. Methods Enzymol (2009) 0.83
Development of Fab' fragments of anti-GD(2) immunoliposomes entrapping doxorubicin for experimental therapy of human neuroblastoma. Cancer Lett (2003) 0.82
Improved plasmalogen synthesis using organobarium intermediates. J Org Chem (2007) 0.82
Ultrastructural analysis of 3 hyaluronic acid soft-tissue fillers using scanning electron microscopy. Dermatol Surg (2015) 0.82
Distribution of photosensitizers in bladder cancer spheroids: implications for intravesical instillation of photosensitizers for photodynamic therapy of bladder cancer. J Pharm Pharm Sci (2005) 0.82
Aerosol-based fabrication of modified chitosans and their application for gene transfection. ACS Appl Mater Interfaces (2014) 0.81
Chemosensitization of carcinoma cells using epithelial cell adhesion molecule-targeted liposomal antisense against bcl-2/bcl-xL. Mol Cancer Ther (2006) 0.81
Lateral diffusion coefficients of an eicosanyl-based bisglycerophosphocholine determined by PFG-NMR and FRAP. Langmuir (2007) 0.80
Formation of fibrinogen-based hydrogels using phototriggerable diplasmalogen liposomes. Bioconjug Chem (2002) 0.80
Development of a low toxicity, effective pDNA vector based on noncovalent assembly of bioresponsive amino-β-cyclodextrin:adamantane-poly(vinyl alcohol)-poly(ethylene glycol) transfection complexes. Bioconjug Chem (2012) 0.80
Comparative evaluation of two purification methods of anti-CD19-c-myc-His6-Cys scFv. Protein Expr Purif (2005) 0.80
Ligand-targeted liposomal therapies of neuroblastoma. Curr Med Chem (2007) 0.80
Transendothelial movement of liposomes in vitro mediated by cancer cells, neutrophils or histamine. J Liposome Res (2004) 0.79
Targeting combinations of liposomal drugs to both tumor vasculature cells and tumor cells for the treatment of HER2-positive breast cancer. J Drug Target (2012) 0.79
Use of the post-insertion method for the formation of ligand-coupled liposomes. Cell Mol Biol Lett (2002) 0.79
Inhibition of membrane-associated methyltransferases by a cholesterol-based metal chelator. Bioconjug Chem (2005) 0.79
Acid-triggered release via dePEGylation of fusogenic liposomes mediated by heterobifunctional phenyl-substituted vinyl ethers with tunable pH-sensitivity. Bioconjug Chem (2012) 0.79
Effect of pendant group on pDNA delivery by cationic-β-cyclodextrin:alkyl-PVA-PEG pendant polymer complexes. Biomacromolecules (2013) 0.79
DNA-vaccine platform development against H1N1 subtype of swine influenza A viruses. Viral Immunol (2012) 0.79
pH-responsive movement of cucurbit[7]uril in a diblock polypseudorotaxane containing dimethyl beta-cyclodextrin and cucurbit[7]uril. Org Lett (2006) 0.79
Prediction of human skin permeability using a combination of molecular orbital calculations and artificial neural network. Biol Pharm Bull (2002) 0.79
The effects of light intensity and light-curing time on the degree of polymerization of dental composite resins. Dent Mater J (2008) 0.78
Molecular weight analyses and enzymatic degradation profiles of the soft-tissue fillers Belotero Balance, Restylane, and Juvéderm Ultra. Plast Reconstr Surg (2013) 0.78
Effective targeted gene delivery to dendritic cells via synergetic interaction of mannosylated lipid with DOPE and BCAT. Biomacromolecules (2012) 0.78
Targeted delivery system for antisense oligonucleotides: a novel experimental strategy for neuroblastoma treatment. Cancer Lett (2003) 0.78
DNA-epitope vaccine provided efficient protection to mice against lethal dose of influenza A virus H1N1. Viral Immunol (2014) 0.78
Risk analysis of feline immunodeficiency virus infection in Tsushima leopard cats (Prionailurus bengalensis euptilurus) and domestic cats using a geographic information system. J Vet Med Sci (2010) 0.78
Direct synthesis of plasmenylcholine from allyl-substituted glycerols. J Org Chem (2003) 0.77
Long-term therapeutic effectiveness of maintenance enteral nutrition for Crohn's disease. Pediatr Int (2015) 0.76
AFM investigations of phase separation in supported membranes of binary mixtures of POPC and an eicosanyl-based bisphosphocholine bolalipid. Langmuir (2010) 0.76